References
1. Agrawal R, Woodfolk JA. Skin Barrier Defects in Atopic Dermatitis.
Curr Allergy Asthma Rep. 2014;14:433.
2. Palmer CNA, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP,
et al. Common loss-of-function variants of the epidermal barrier protein
filaggrin are a major predisposing factor for atopic dermatitis. Nat
Genet. 2006;38:441–6.
3. Newell L, Polak ME, Perera J, Owen C, Boyd P, Pickard C, et al.
Sensitization via healthy skin programs Th2 responses in individuals
with atopic dermatitis. J Invest Dermatol. 2013;133:2372–80.
4. Boralevi F, Hubiche T, Léauté-Labrèze C, Saubusse E, Fayon M, Roul S,
et al. Epicutaneous aeroallergen sensitization in atopic dermatitis
infants - determining the role of epidermal barrier impairment. Allergy.
2008;63:205–10.
5. Fox DE, Lack G. Peanut allergy. Lancet. 1998;352:741.
6. Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF,
et al. Randomized trial of peanut consumption in infants at risk for
peanut allergy. N Engl J Med. 2015;372:803–13.
7. Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, et al.
Randomized Trial of Introduction of Allergenic Foods in Breast-Fed
Infants. N Engl J Med. 2016;374:1733–43.
8. Natsume O, Kabashima S, Nakazato J, Yamamoto-Hanada K, Narita M,
Kondo M, et al. Two-step egg introduction for prevention of egg allergy
in high-risk infants with eczema (PETIT): a randomised, double-blind,
placebo-controlled trial. Lancet. 2017;389:276–86.
9. Presland RB, Dale BA. Epithelial structural proteins of the skin and
oral cavity: function in health and disease. Crit Rev Oral Biol Med.
2000;11:383–408.
10. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J
Allergy Clin Immunol. 2003;112:S118-127.
11. Bisgaard H. The Copenhagen Prospective Study on Asthma in Childhood
(COPSAC): design, rationale, and baseline data from a longitudinal birth
cohort study. Ann Allergy Asthma Immunol. 2004;93:381–9.
12. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F.
Intermittent inhaled corticosteroids in infants with episodic wheezing.
N Engl J Med. 2006;354:1998–2005.
13. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB,
Bønnelykke K, et al. Childhood asthma after bacterial colonization of
the airway in neonates. N Engl J Med. 2007;357:1487–95.
14. Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta
Derm Venereol. 1980;92:44–7.
15. Thorsteinsdottir S, Stokholm J, Thyssen JP, Nørgaard S, Thorsen J,
Chawes BL, et al. Genetic, Clinical, and Environmental Factors
Associated With Persistent Atopic Dermatitis in Childhood. JAMA
Dermatol. 2019;155:50–7.
16. If R, S T, S N, Bl C, K B, J S, et al. Symptom burden of atopic
dermatitis in early childhood assessed from daily monitoring of symptoms
and topical steroid usage [Internet]. Journal of the American
Academy of Dermatology. J Am Acad Dermatol; 2020 [cited 2020 Dec 2].
Available from: https://pubmed.ncbi.nlm.nih.gov/32950548/
17. Severity scoring of atopic dermatitis: the SCORAD index. Consensus
Report of the European Task Force on Atopic Dermatitis. Dermatology
(Basel). 1993;186:23–31.
18. Paganelli R, Ansotegui IJ, Sastre J, Lange CE, Roovers MH, de Groot
H, et al. Specific IgE antibodies in the diagnosis of atopic disease.
Clinical evaluation of a new in vitro test system, UniCAP, in six
European allergy clinics. Allergy. 1998;53:763–8.
19. Braun-Fahrländer C, Wüthrich B, Gassner M, Grize L, Sennhauser FH,
Varonier HS, et al. Validation of a rhinitis symptom questionnaire
(ISAAC core questions) in a population of Swiss school children visiting
the school health services. SCARPOL-team. Swiss Study on Childhood
Allergy and Respiratory Symptom with respect to Air Pollution and
Climate. International Study of Asthma and Allergies in Childhood.
Pediatr Allergy Immunol. 1997;8:75–82.
20. Chawes BLK. Upper and lower airway pathology in young children with
allergic- and non-allergic rhinitis. Dan Med Bull. 2011;58:B4278.
21. Chawes BLK, Bønnelykke K, Kreiner-Møller E, Bisgaard H. Children
with allergic and nonallergic rhinitis have a similar risk of asthma. J
Allergy Clin Immunol. 2010;126:567-573.e1-8.
22. Chawes BLK, Kreiner-Møller E, Bisgaard H. Objective assessments of
allergic and nonallergic rhinitis in young children. Allergy.
2009;64:1547–53.
23. Gustafsson D, Sjöberg O, Foucard T. Development of allergies and
asthma in infants and young children with atopic dermatitis–a
prospective follow-up to 7 years of age. Allergy. 2000;55:240–5.
24. von Kobyletzki LB, Bornehag C-G, Hasselgren M, Larsson M, Lindström
CB, Svensson Å. Eczema in early childhood is strongly associated with
the development of asthma and rhinitis in a prospective cohort. BMC
Dermatol. 2012;12:11.
25. Wahn U, Warner J, Simons FER, de Benedictis FM, Diepgen TL, Naspitz
CK, et al. IgE antibody responses in young children with atopic
dermatitis. Pediatr Allergy Immunol. 2008;19:332–6.
26. Gustafsson D, Sjöberg O, Foucard T. Sensitization to food and
airborne allergens in children with atopic dermatitis followed up to 7
years of age. Pediatr Allergy Immunol. 2003;14:448–52.
27. Kjellman B, Hattevig G. Allergy in early and late onset of atopic
dermatitis. Acta Paediatrica. 1994;83:229–31.
28. Wan J, Mitra N, Hoffstad OJ, Gelfand JM, Yan AC, Margolis DJ.
Variations in risk of asthma and seasonal allergies between early and
late onset pediatric atopic dermatitis: a cohort study. J Am Acad
Dermatol. 2017;77:634–40.
29. Möhrenschlager M, Schäfer T, Huss-Marp J, Eberlein-König B,
Weidinger S, Ring J, et al. The course of eczema in children aged 5-7
years and its relation to atopy: differences between boys and girls. The
British Journal of Dermatology. 2006;154:505–13.
30. Carlsten C, Dimich-Ward H, Ferguson A, Watson W, Rousseau R,
DyBuncio A, et al. Atopic dermatitis in a high-risk cohort: natural
history, associated allergic outcomes, and risk factors. Annals of
Allergy, Asthma & Immunology. 2013;110:24–8.
31. Lowe AJ, Angelica B, Su J, Lodge CJ, Hill DJ, Erbas B, et al. Age at
onset and persistence of eczema are related to subsequent risk of asthma
and hay fever from birth to 18 years of age. Pediatr Allergy Immunol.
2017;28:384–90.
32. Kuo I-H, Yoshida T, Benedetto AD, Beck LA. The cutaneous innate
immune response in patients with atopic dermatitis. Journal of Allergy
and Clinical Immunology. 2013;131:266–78.
33. Ferreira MA, Vonk JM, Baurecht H, Marenholz I, Tian C, Hoffman JD,
et al. Shared genetic origin of asthma, hay fever and eczema elucidates
allergic disease biology. Nat Genet. 2017;49:1752–7.
34. Zheng T, Yu J, Oh MH, Zhu Z. The atopic march: progression from
atopic dermatitis to allergic rhinitis and asthma. Allergy Asthma
Immunol Res. 2011;3:67–73.
35. McGrath JA, Uitto J. The filaggrin story: novel insights into
skin-barrier function and disease. Trends Mol Med. 2008;14:20–7.
36. Demehri S, Morimoto M, Holtzman MJ, Kopan R. Skin-derived TSLP
triggers progression from epidermal-barrier defects to asthma. PLoS
Biol. 2009;7:e1000067.
37. Chalmers JR, Haines RH, Bradshaw LE, Montgomery AA, Thomas KS, Brown
SJ, et al. Daily emollient during infancy for prevention of eczema: the
BEEP randomised controlled trial. The Lancet. 2020;395:962–72.
38. Skjerven HO, Rehbinder EM, Vettukattil R, LeBlanc M, Granum B,
Haugen G, et al. Skin emollient and early complementary feeding to
prevent infant atopic dermatitis (PreventADALL): a factorial,
multicentre, cluster-randomised trial. Lancet. 2020;395:951–61.
39. Grindebacke H, Stenstad H, Quiding-Järbrink M, Waldenström J,
Adlerberth I, Wold AE, et al. Dynamic development of homing receptor
expression and memory cell differentiation of infant CD4+CD25high
regulatory T cells. J Immunol. 2009;183:4360–70.
40. Sato MN, Carvalho AF, Silva AO, MacIel M, Fusaro AE, Duarte AJ. Oral
tolerance induced to house dust mite extract in naive and sensitized
mice: evaluation of immunoglobulin G anti-immunoglobulin E
autoantibodies and IgG-IgE complexes. Immunology. 1998;95:193–9.
41. Holt PG, Sly PD, Sampson HA, Robinson P, Loh R, Lowenstein H, et al.
Prophylactic use of sublingual allergen immunotherapy in high-risk
children: a pilot study. J Allergy Clin Immunol. 2013;132:991-993.e1.
42. Zolkipli Z, Roberts G, Cornelius V, Clayton B, Pearson S, Michaelis
L, et al. Randomized controlled trial of primary prevention of atopy
using house dust mite allergen oral immunotherapy in early childhood. J
Allergy Clin Immunol. 2015;136:1541-1547.e11.
43. Alviani C, Roberts G, Moyses H, Pearson S, Larsson M, Zolkipli Z, et
al. Follow-up, 18 months off house dust mite immunotherapy, of a
randomized controlled study on the primary prevention of atopy. Allergy.
2019;74:1406–8.